3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)

Clinical trial NCT04144413 · COMPLETED

Trial details

NCT number: NCT04144413
Sponsor: Santen SAS
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease With Severe Keratitis

Start date: 2019-05-31
Primary completion: 2023-07-14
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.